← All Nutra Pharma CORP filings

Nutra Pharma CORP 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OTC.Pink
NPHC
Nutra Pharma CORP
8-K: Nutra Pharma Corp. Reports Change in Control
Nutra Pharma Corp. announced a change in control on August 21, 2026, with Pure Raw Supplies, LLC acquiring controlling voting power through a gift of Series B Preferred Stock.
OTC.Pink
NPHC
Nutra Pharma CORP
8-K: Nutra Pharma Changes Auditors Amid Internal Control Weaknesses
Nutra Pharma Corp. announced the resignation of Marcum LLP as its independent auditor and the appointment of Astra Audit & Advisory, citing material weaknesses in internal controls.
OTC.Pink
NPHC
Nutra Pharma CORP
8-K: Nutra Pharma Corp. Announces Leadership Changes and SEC Settlement
Nutra Pharma Corp. has announced the resignation of its CEO, Rik J. Deitsch, following a settlement with the SEC, and the appointment of Dr. Michael Flax as the new CEO, Chairman, and CFO.